7 valent pneumococcal conjugate vaccine

BIOLOGICAL3 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer, Pfizer

Conditions

Pneumococcal InfectionsVaccines, Pneumococcal

Phase 3

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Infants

CompletedNCT00366899

Wyeth is now a wholly owned subsidiary of PfizerVaccines, Pneumococcal

Start: 2006-10-31End: 2008-07-31Updated: 2013-02-22

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in India

CompletedNCT00452790

Wyeth is now a wholly owned subsidiary of PfizerPneumococcal Infections

Start: 2007-06-30End: 2010-02-28Updated: 2011-03-24

Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization

CompletedNCT00508742

PfizerPneumococcal Infections

Start: 2007-12-31End: 2011-08-31Updated: 2013-05-10

Related Papers

Carrier-Induced Hyporesponsiveness to Pneumococcal Conjugate Vaccines: Unraveling the Influence of Serotypes, Timing, and Previous Vaccine Dose

Clinical Infectious Diseases2020-01-2710 citations

PCV13-vaccinated children still carrying PCV13 additional serotypes show similar carriage density to a control group of PCV7-vaccinated children.

2017-01-1117 citations

Modeling pneumococcal nasopharyngeal acquisition as a function of anticapsular serum antibody concentrations after pneumococcal conjugate vaccine administration.

2016-07-1234 citations

Efficacy of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus That of 7-Valent PCV (PCV7) Against Nasopharyngeal Colonization of Antibiotic-Nonsusceptible<i>Streptococcus pneumoniae</i>

The Journal of Infectious Diseases2014-10-2975 citations

Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial

Clinical Infectious Diseases2013-06-26246 citations